Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Davis ZB"'
Autor:
Dixon KJ; Department of Veterinary and Biomedical Sciences, University of Minnesota, St. Paul, MN, United States., Snyder KM; Department of Veterinary and Biomedical Sciences, University of Minnesota, St. Paul, MN, United States., Khaw M; Division of Hematology, Oncology, and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN, United States., Hullsiek R; Department of Veterinary and Biomedical Sciences, University of Minnesota, St. Paul, MN, United States., Davis ZB; Division of Hematology, Oncology, and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN, United States., Matson AW; Department of Veterinary and Biomedical Sciences, University of Minnesota, St. Paul, MN, United States., Shirinbak S; Fate Therapeutics, San Diego, CA, United States., Hancock B; Fate Therapeutics, San Diego, CA, United States., Bjordahl R; Fate Therapeutics, San Diego, CA, United States., Hosking M; Fate Therapeutics, San Diego, CA, United States., Miller JS; Division of Hematology, Oncology, and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN, United States.; Center for Immunology, University of Minnesota, Minneapolis, MN, United States.; Masonic Cancer Center, University of Minnesota, Minneapolis, MN, United States., Valamehr B; Fate Therapeutics, San Diego, CA, United States., Wu J; Department of Veterinary and Biomedical Sciences, University of Minnesota, St. Paul, MN, United States.; Masonic Cancer Center, University of Minnesota, Minneapolis, MN, United States., Walcheck B; Department of Veterinary and Biomedical Sciences, University of Minnesota, St. Paul, MN, United States.; Center for Immunology, University of Minnesota, Minneapolis, MN, United States.; Masonic Cancer Center, University of Minnesota, Minneapolis, MN, United States.; Stem Cell Institute, University of Minnesota, Minneapolis, MN, United States.
Publikováno v:
Frontiers in immunology [Front Immunol] 2024 Jul 19; Vol. 15, pp. 1407567. Date of Electronic Publication: 2024 Jul 19 (Print Publication: 2024).
Safety and Virologic Impact of Haploidentical NK Cells Plus Interleukin 2 or N-803 in HIV Infection.
Autor:
Miller JS; Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA., Rhein J; Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA., Davis ZB; Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA., Cooley S; Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA., McKenna D; Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, Minnesota, USA., Anderson J; Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA., Escandón K; Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA., Wieking G; Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA., Reichel J; Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA., Thorkelson A; Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA., Jorstad S; Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA., Safrit JT; ImmunityBio, Culver City, California, USA., Soon-Shiong P; ImmunityBio, Culver City, California, USA., Beilman GJ; Department of Surgery, University of Minnesota, Minneapolis, Minnesota, USA., Chipman JG; Department of Surgery, University of Minnesota, Minneapolis, Minnesota, USA., Schacker TW; Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA.
Publikováno v:
The Journal of infectious diseases [J Infect Dis] 2024 May 15; Vol. 229 (5), pp. 1256-1265.
Autor:
Davis ZB; Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania., Zeiger JS; Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania., Shields CL; Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania.
Publikováno v:
Ophthalmology. Retina [Ophthalmol Retina] 2023 Jul; Vol. 7 (7), pp. 648. Date of Electronic Publication: 2023 Apr 12.
Autor:
Fares J; Department of Neurological Surgery, Feinberg School of Medicine, Northwestern University, Chicago, IL, 60611, USA.; Northwestern Medicine Malnati Brain Tumor Institute, Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL, 60611, USA., Davis ZB; Department of Medicine, Division of Hematology, Oncology and Transplantation, Masonic Cancer Center, University of Minnesota, Minneapolis, MN, 55454, USA., Rechberger JS; Department of Neurologic Surgery, Mayo Clinic, Rochester, MN, 55905, USA.; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic Graduate School of Biomedical Sciences, Rochester, MN, 55905, USA., Toll SA; Department of Pediatrics, Division of Hematology/Oncology, Children's Hospital of Michigan, Detroit, MI, 48201, USA., Schwartz JD; Department of Pediatric Hematology/Oncology, Section of Neuro-Oncology, Mayo Clinic, Rochester, MN, 55905, USA., Daniels DJ; Department of Neurologic Surgery, Mayo Clinic, Rochester, MN, 55905, USA.; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic Graduate School of Biomedical Sciences, Rochester, MN, 55905, USA., Miller JS; Department of Medicine, Division of Hematology, Oncology and Transplantation, Masonic Cancer Center, University of Minnesota, Minneapolis, MN, 55454, USA. mille011@umn.edu., Khatua S; Department of Pediatric Hematology/Oncology, Section of Neuro-Oncology, Mayo Clinic, Rochester, MN, 55905, USA. skhatua.bappa@gmail.com.
Publikováno v:
NPJ precision oncology [NPJ Precis Oncol] 2023 Feb 15; Vol. 7 (1), pp. 17. Date of Electronic Publication: 2023 Feb 15.
Autor:
Cichocki F; Department of Medicine, University of Minnesota, Minneapolis, MN., Goodridge JP; Fate Therapeutics, San Diego, CA., Bjordahl R; Fate Therapeutics, San Diego, CA., Mahmood S; Fate Therapeutics, San Diego, CA., Davis ZB; Department of Medicine, University of Minnesota, Minneapolis, MN., Gaidarova S; Fate Therapeutics, San Diego, CA., Abujarour R; Fate Therapeutics, San Diego, CA., Groff B; Fate Therapeutics, San Diego, CA., Witty A; Fate Therapeutics, San Diego, CA., Wang H; Department of Medicine, University of Minnesota, Minneapolis, MN., Tuininga K; Department of Medicine, University of Minnesota, Minneapolis, MN., Kodal B; Department of Medicine, University of Minnesota, Minneapolis, MN., Felices M; Department of Medicine, University of Minnesota, Minneapolis, MN., Bonello G; Fate Therapeutics, San Diego, CA., Huffman J; Fate Therapeutics, San Diego, CA., Dailey T; Fate Therapeutics, San Diego, CA., Lee TT; Fate Therapeutics, San Diego, CA., Walcheck B; Department of Veterinary and Biomedical Sciences, University of Minnesota, St. Paul, MN., Valamehr B; Fate Therapeutics, San Diego, CA., Miller JS; Department of Medicine, University of Minnesota, Minneapolis, MN.
Publikováno v:
Blood [Blood] 2022 Dec 08; Vol. 140 (23), pp. 2451-2462.
Autor:
Cichocki F; University of Minnesota, Department of Medicine, Minneapolis, MN, 55455, USA., Bjordahl R; Fate Therapeutics, San Diego, CA, 92121, USA., Goodridge JP; Fate Therapeutics, San Diego, CA, 92121, USA., Mahmood S; Fate Therapeutics, San Diego, CA, 92121, USA., Gaidarova S; Fate Therapeutics, San Diego, CA, 92121, USA., Abujarour R; Fate Therapeutics, San Diego, CA, 92121, USA., Davis ZB; University of Minnesota, Department of Medicine, Minneapolis, MN, 55455, USA., Merino A; University of Minnesota, Department of Medicine, Minneapolis, MN, 55455, USA., Tuininga K; University of Minnesota, Department of Medicine, Minneapolis, MN, 55455, USA., Wang H; University of Minnesota, Department of Medicine, Minneapolis, MN, 55455, USA., Kumar A; University of Minnesota, Department of Medicine, Minneapolis, MN, 55455, USA., Groff B; Fate Therapeutics, San Diego, CA, 92121, USA., Witty A; Fate Therapeutics, San Diego, CA, 92121, USA., Bonello G; Fate Therapeutics, San Diego, CA, 92121, USA., Huffman J; Fate Therapeutics, San Diego, CA, 92121, USA., Dailey T; Fate Therapeutics, San Diego, CA, 92121, USA., Lee TT; Fate Therapeutics, San Diego, CA, 92121, USA., Malmberg KJ; Oslo University Hospital, Oslo, Norway., Walcheck B; University of Minnesota, Department of Veterinary and Biomedical Sciences, St. Paul, MN, 55108, USA., Höpken U; Max-Delbrück-Center for Molecular Medicine, MDC, Berlin, Germany., Rehm A; Max-Delbrück-Center for Molecular Medicine, MDC, Berlin, Germany., Valamehr B; Fate Therapeutics, San Diego, CA, 92121, USA. bob.valamehr@fatetherapeutics.com., Miller JS; University of Minnesota, Department of Medicine, Minneapolis, MN, 55455, USA. mille011@umn.edu.
Publikováno v:
Nature communications [Nat Commun] 2022 Nov 29; Vol. 13 (1), pp. 7341. Date of Electronic Publication: 2022 Nov 29.
Autor:
Miller JS; Department of Medicine, University of Minnesota Medical School, Minneapolis, MN, USA., Davis ZB; Department of Medicine, University of Minnesota Medical School, Minneapolis, MN, USA., Helgeson E; Division of Biostatistics, University of Minnesota School of Public Health, Minneapolis, MN, USA., Reilly C; Division of Biostatistics, University of Minnesota School of Public Health, Minneapolis, MN, USA., Thorkelson A; Department of Medicine, University of Minnesota Medical School, Minneapolis, MN, USA., Anderson J; Department of Medicine, University of Minnesota Medical School, Minneapolis, MN, USA., Lima NS; Human Immunology Section, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Jorstad S; Department of Medicine, University of Minnesota Medical School, Minneapolis, MN, USA., Hart GT; Department of Medicine, University of Minnesota Medical School, Minneapolis, MN, USA., Lee JH; ImmunityBio, Culver City, CA, USA., Safrit JT; ImmunityBio, Culver City, CA, USA., Wong H; HCW Biologics, Miramar, FL, USA.; HCW Biologics but was with Altor BioSciences at the start of the study, Miramar FL, USA., Cooley S; Department of Medicine, University of Minnesota Medical School, Minneapolis, MN, USA.; Fate Therapeutics, San Diego, CA, USA., Gharu L; Human Immunology Section, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Chung H; Human Immunology Section, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Soon-Shiong P; ImmunityBio, Culver City, CA, USA., Dobrowolski C; Department of Molecular Biology and Microbiology, Medical School, Case Western Reserve University, Cleveland, OH, USA.; Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory School of Medicine, Atlanta, GA, USA., Fletcher CV; Antiviral Pharmacology Laboratory, UNMC Center for Drug Discovery, University of Nebraska Medical Center, Omaha, NE, USA., Karn J; Department of Molecular Biology and Microbiology, Medical School, Case Western Reserve University, Cleveland, OH, USA., Douek DC; Human Immunology Section, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Schacker TW; Department of Medicine, University of Minnesota Medical School, Minneapolis, MN, USA. schacker@umn.edu.
Publikováno v:
Nature medicine [Nat Med] 2022 Feb; Vol. 28 (2), pp. 392-400. Date of Electronic Publication: 2022 Jan 31.
Autor:
Woan KV; University of Minnesota, Department of Medicine, Minneapolis, MN 55455, USA., Kim H; University of Minnesota, Department of Medicine, Minneapolis, MN 55455, USA., Bjordahl R; Fate Therapeutics, San Diego, CA 92121, USA., Davis ZB; University of Minnesota, Department of Medicine, Minneapolis, MN 55455, USA., Gaidarova S; Fate Therapeutics, San Diego, CA 92121, USA., Goulding J; Fate Therapeutics, San Diego, CA 92121, USA., Hancock B; Fate Therapeutics, San Diego, CA 92121, USA., Mahmood S; Fate Therapeutics, San Diego, CA 92121, USA., Abujarour R; Fate Therapeutics, San Diego, CA 92121, USA., Wang H; University of Minnesota, Department of Medicine, Minneapolis, MN 55455, USA., Tuininga K; University of Minnesota, Department of Medicine, Minneapolis, MN 55455, USA., Zhang B; University of Minnesota, Department of Medicine, Minneapolis, MN 55455, USA., Wu CY; University of Minnesota, Department of Medicine, Minneapolis, MN 55455, USA., Kodal B; University of Minnesota, Department of Medicine, Minneapolis, MN 55455, USA., Khaw M; University of Minnesota, Department of Medicine, Minneapolis, MN 55455, USA., Bendzick L; University of Minnesota, Department of Medicine, Minneapolis, MN 55455, USA., Rogers P; Fate Therapeutics, San Diego, CA 92121, USA., Ge MQ; Fate Therapeutics, San Diego, CA 92121, USA., Bonello G; Fate Therapeutics, San Diego, CA 92121, USA., Meza M; Fate Therapeutics, San Diego, CA 92121, USA., Felices M; University of Minnesota, Department of Medicine, Minneapolis, MN 55455, USA., Huffman J; Fate Therapeutics, San Diego, CA 92121, USA., Dailey T; Fate Therapeutics, San Diego, CA 92121, USA., Lee TT; Fate Therapeutics, San Diego, CA 92121, USA., Walcheck B; University of Minnesota, Department of Veterinary and Biomedical Sciences, St. Paul, MN 55108, USA., Malmberg KJ; KG Jebsen Center for Cancer Immunotherapy, Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Department of Cancer Immunotherapy, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway; Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden., Blazar BR; University of Minnesota, Department of Pediatrics, Minneapolis, MN 55455, USA., Bryceson YT; Broegelmann Research Laboratory, Department of Clinical Sciences, University of Bergen, Bergen, Norway; Centre for Hematology and Regenerative Medicine, Department of Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden., Valamehr B; Fate Therapeutics, San Diego, CA 92121, USA., Miller JS; University of Minnesota, Department of Medicine, Minneapolis, MN 55455, USA. Electronic address: mille011@umn.edu., Cichocki F; University of Minnesota, Department of Medicine, Minneapolis, MN 55455, USA. Electronic address: cich0040@umn.edu.
Publikováno v:
Cell stem cell [Cell Stem Cell] 2021 Dec 02; Vol. 28 (12), pp. 2062-2075.e5. Date of Electronic Publication: 2021 Sep 14.
Autor:
Cichocki F; Department of Medicine, University of Minnesota, Minneapolis, MN 55455, USA., Bjordahl R; Fate Therapeutics, San Diego, CA 92121, USA., Gaidarova S; Fate Therapeutics, San Diego, CA 92121, USA., Mahmood S; Fate Therapeutics, San Diego, CA 92121, USA., Abujarour R; Fate Therapeutics, San Diego, CA 92121, USA., Wang H; Department of Medicine, University of Minnesota, Minneapolis, MN 55455, USA., Tuininga K; Department of Medicine, University of Minnesota, Minneapolis, MN 55455, USA., Felices M; Department of Medicine, University of Minnesota, Minneapolis, MN 55455, USA., Davis ZB; Department of Medicine, University of Minnesota, Minneapolis, MN 55455, USA., Bendzick L; Department of Medicine, University of Minnesota, Minneapolis, MN 55455, USA., Clarke R; Fate Therapeutics, San Diego, CA 92121, USA., Stokely L; Fate Therapeutics, San Diego, CA 92121, USA., Rogers P; Fate Therapeutics, San Diego, CA 92121, USA., Ge M; Fate Therapeutics, San Diego, CA 92121, USA., Robinson M; Fate Therapeutics, San Diego, CA 92121, USA., Rezner B; Fate Therapeutics, San Diego, CA 92121, USA., Robbins DL; Fate Therapeutics, San Diego, CA 92121, USA., Lee TT; Fate Therapeutics, San Diego, CA 92121, USA., Kaufman DS; Department of Medicine, Division of Regenerative Medicine, Moores Cancer Center, and Sanford Consortium for Regenerative Medicine, University of California, San Diego, La Jolla, CA 92093, USA., Blazar BR; Department of Pediatrics, University of Minnesota, Minneapolis, MN 55455, USA., Valamehr B; Fate Therapeutics, San Diego, CA 92121, USA. mille011@umn.edu bob.valamehr@fatetherapeutics.com., Miller JS; Department of Medicine, University of Minnesota, Minneapolis, MN 55455, USA. mille011@umn.edu bob.valamehr@fatetherapeutics.com.
Publikováno v:
Science translational medicine [Sci Transl Med] 2020 Nov 04; Vol. 12 (568).
Autor:
Davis ZB; Division of Hematology, Oncology, and Transplantation, Department of Medicine, University of Minnesota, United States; Masonic Cancer Center, University of Minnesota, United States., Vallera DA; Masonic Cancer Center, University of Minnesota, United States; Department of Therapeutic Radiology-Radiation Oncology, University of Minnesota, United States., Miller JS; Division of Hematology, Oncology, and Transplantation, Department of Medicine, University of Minnesota, United States; Masonic Cancer Center, University of Minnesota, United States. Electronic address: mille011@umn.edu., Felices M; Division of Hematology, Oncology, and Transplantation, Department of Medicine, University of Minnesota, United States; Masonic Cancer Center, University of Minnesota, United States.
Publikováno v:
Seminars in immunology [Semin Immunol] 2017 Jun; Vol. 31, pp. 64-75. Date of Electronic Publication: 2017 Sep 05.